Inception cohort | Non-inception cohort | |||||
---|---|---|---|---|---|---|
Whole group | Females | Males | Whole group | Females | Males | |
n | 111 | 59 | 52 | 635 | 424 | 211 |
age | 42.5 (12.3) | 44.4 (12.5) | 40.4 (11.7) | 45.5 (12.9) | 46.7 (13) | 43.1 (12.4) |
SJC | 2.7 (3.4) | 2.5 (3.2) | 3 (3.6) | 1.6 (2.8) | 1.5 (2.8) | 1.6 (2.7) |
TJC | 4.1 (4) | 3.8 (3.7) | 4.5 (4.2) | 3.4 (4.7) | 3.5 (4.8) | 3.4 (4.2) |
BASDAI* | 4.5 (2.4) | 4.3 (2.2) | 4.8 (2.5) | 3.7 (3.8) | 3.8 (4.3) | 3.5 (2.6) |
BASFI* | 3.2 (2.4) | 3 (2.3) | 3.4 (2.4) | 2.8 (2.7) | 2.7 (2.7) | 2.8 (2.7) |
Patient global* | 4.9 (2.5) | 4.7 (2.3) | 5.1 (2.6) | 3.9 (2.3) | 4 (2.3) | 3.5 (2.4) |
Physician global* | 4.2 (1.9) | 4 (1.6) | 4.4 (2.1) | 3.1 (2.1) | 3.1 (2) | 3 (2.2) |
fatigue* | 4.9 (2.5) | 5 (2.3) | 4.9 (2.7) | 4.2 (2.6) | 4.5 (2.5) | 3.7 (2.8) |
CRP (mg/lt) | 13. 4 (23.4) | 9.5 (16.5) | 18 (29.1) | 8.7 (16.2) | 8.6 (16.1) | 9 (16.5) |
↵* Data given on a scale between 0–10. There were missing data. The number of cases with available information are: BASDAI: 434, BASFI: 413; patient global assessment: 493; physician global assessment 440, fatigue: 506, CRP: 717, tender joint count: 677, swollen joint count: 672.